These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26130695)

  • 41. A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
    Vijai J; Topka S; Villano D; Ravichandran V; Maxwell KN; Maria A; Thomas T; Gaddam P; Lincoln A; Kazzaz S; Wenz B; Carmi S; Schrader KA; Hart SN; Lipkin SM; Neuhausen SL; Walsh MF; Zhang L; Lejbkowicz F; Rennert H; Stadler ZK; Robson M; Weitzel JN; Domchek S; Daly MJ; Couch FJ; Nathanson KL; Norton L; Rennert G; Offit K
    Cancer Discov; 2016 Nov; 6(11):1267-1275. PubMed ID: 27655433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry.
    Nguyen-Dumont T; Hammet F; Mahmoodi M; Tsimiklis H; Teo ZL; Li R; Pope BJ; Terry MB; Buys SS; Daly M; Hopper JL; Winship I; Goldgar DE; Park DJ; Southey MC
    Breast Cancer Res Treat; 2015 Jan; 149(2):547-54. PubMed ID: 25575445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
    Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.
    Popanda O; Seibold P; Nikolov I; Oakes CC; Burwinkel B; Hausmann S; Flesch-Janys D; Plass C; Chang-Claude J; Schmezer P
    Int J Cancer; 2013 Jan; 132(1):55-62. PubMed ID: 22684821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry.
    Kappil M; Terry MB; Delgado-Cruzata L; Liao Y; Santella RM
    Anticancer Res; 2016 Sep; 36(9):4437-41. PubMed ID: 27630279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
    Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
    Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
    Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
    BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case-control study.
    Brandalize AP; Schüler-Faccini L; Hoffmann JS; Caleffi M; Cazaux C; Ashton-Prolla P
    BMC Cancer; 2014 Nov; 14():850. PubMed ID: 25409685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
    Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of NF1 allele containing two nonsense mutations in exon 37 that segregates with neurofibromatosis type 1.
    Hernández-Imaz E; Campos B; Rodríguez-Álvarez FJ; Abad O; Melean G; Gardenyes J; Martín Y; Hernández-Chico C
    Clin Genet; 2013 May; 83(5):462-6. PubMed ID: 22925204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.
    Frank B; Bermejo JL; Hemminki K; Sutter C; Wappenschmidt B; Meindl A; Kiechle-Bahat M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
    Carcinogenesis; 2007 Jul; 28(7):1442-5. PubMed ID: 17301065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
    Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
    Frank B; Hemminki K; Meindl A; Wappenschmidt B; Klaes R; Schmutzler RK; Untch M; Bugert P; Bartram CR; Burwinkel B
    Int J Cancer; 2006 May; 118(10):2505-8. PubMed ID: 16353159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
    Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
    Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
    Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
    Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
    PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.